News
ATR
142.48
+1.40%
1.97
Top AptarGroup Executive Makes Eye-Catching Move With Company Stock
TipRanks · 1d ago
AptarGroup (ATR) Valuation Check After Q4 Sales Growth And New US$600 Million Buyback Authorization
Simply Wall St · 3d ago
AptarGroup Earnings Call Balances Growth With Margin Strain
TipRanks · 3d ago
Bullish Two Hundred Day Moving Average Cross - ATR
NASDAQ · 4d ago
AptarGroup price target raised to $147 from $142 at BofA
TipRanks · 4d ago
AptarGroup price target raised to $156 from $145 at Baird
TipRanks · 4d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: PTC Therapeutics (PTCT), AptarGroup (ATR) and Encompass Health (EHC)
TipRanks · 4d ago
Balanced View on AptarGroup: Solid Underlying Pharma Performance Offset by Near-Term Headwinds and Underwhelming Beauty & Closures, Justifying a Hold Rating
TipRanks · 4d ago
Weekly Report: what happened at ATR last week (0202-0206)?
Weekly Report · 4d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Dianthus Therapeutics (DNTH) and AptarGroup (ATR)
TipRanks · 4d ago
AptarGroup (ATR) Slower 4.9% Earnings Growth Tests Long Term Bullish Narrative
Simply Wall St · 6d ago
AptarGroup outlines 2026 margin improvement and targets 7%–11% long-term pharma core sales growth amid emergency medicine headwinds
Seeking Alpha · 02/06 20:45
AptarGroup Gains After 4Q Results, Buyback Plan
Dow Jones · 02/06 18:32
AptarGroup Up Over 7%, on Pace for Largest Percent Increase Since April -- Data Talk
Dow Jones · 02/06 16:36
AptarGroup declares $0.48 dividend
Seeking Alpha · 02/06 14:43
William Blair Releases a Hold Rating on AptarGroup (ATR)
TipRanks · 02/06 05:56
How Strong Q4 Results and FX-Tied Guidance Will Impact AptarGroup (ATR) Investors
Simply Wall St · 02/06 03:10
AptarGroup (ATR) Reports Q4 Earnings: What Key Metrics Have to Say
NASDAQ · 02/06 00:00
AptarGroup Inc. Reveals Drop In Q4 Income
NASDAQ · 02/05 22:27
Press Release: Aptar Reports Fourth Quarter and Annual 2025 Results
Dow Jones · 02/05 22:04
More
Webull provides a variety of real-time ATR stock news. You can receive the latest news about Aptargroup through multiple platforms. This information may help you make smarter investment decisions.
About ATR
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. It operates in three segments. The Aptar Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions and services for the prescription drug, consumer health care, injectables, active material science solutions and digital health market. It also specializes in nasal drug delivery for delivering drugs. The Aptar Beauty segment sells dispensing systems and sealing solutions for the beauty, personal care and home care markets. The Aptar Closures segment sells dispensing systems, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and healthcare markets. This segment also includes the food protection business and the elastomeric flow-control technology business.